721MO Phase I, two-part, multicenter first-in-human (FIH) study of TORL-1-23: A novel claudin 6 (CLDN6) targeting antibody drug conjugate (ADC) in patient with advanced solid tumors
Konecny, G.E., Hendrickson, A.E. Wahner, Winterhoff, B., Adjei, A.A., Kung, A., Miller, L-L., Press, M.F., Qazi, I., Scholler, N., Dokainish, H., Letrent, S., Slamon, D.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
756P First-in-human phase I study of a novel claudin 6 (CLDN6) targeted antibody drug conjugate (ADC) TORL-1-23
Konecny, G.E., Wahner Hendrickson, A.E., Winterhoff, B., Machado, A., Chander, C., Davenport, S., Bilic, S., Miller, L-L., Chung, A., Press, M.F., Letrent, S., Slamon, D.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Safety and Efficacy Results of Retreatment With a PARP Inhibitor Monotherapy in Late-Line Recurrent Ovarian Cancer: Results From a Subset of the QUADRA Trial
Rimel, B.J., Secord, A.A., Geller, M.A., Miller, D.S., Cloven, N., Fleming, G.F., Hendrickson, A.E. Wahner, Azodi, M., DiSilvestro, P., Oza, A.M., Cristea, M., Berek, J.S., Chan, J.K., Matei, D.E., Li, Y., Sun, K., Luptakova, K., Matulonis, U.A., Monk, B.J., Moore, K.N.
Published in Gynecologic oncology (01.03.2020)
Published in Gynecologic oncology (01.03.2020)
Get full text
Journal Article
LBA60 - Randomized phase II (RP2) study of ATR inhibitor M6620 in combination with gemcitabine versus gemcitabine alone in platinum-resistant high grade serous ovarian cancer (HGSOC)
Konstantinopoulos, P.A., Wahner Hendrickson, A.E., Penson, R.T., Doyle, A., Kohn, E.C., Duska, L.R., Crispens, M.A., Olawaiye, A.B., Winer, I.S., Barroilhet, L.M., Fu, S., McHale, M.T., Schilder, R.J., Farkkila, A., Curtis, J., Quinn, R., Whalen, C., Shapiro, G.I., Matulonis, U.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Randomized phase II (RP2) study of ATR inhibitor M6620 in combination with gemcitabine versus gemcitabine alone in platinum-resistant high grade serous ovarian cancer (HGSOC)
Konstantinopoulos, P.A., Wahner Hendrickson, A.E., Penson, R.T., Doyle, A., Kohn, E.C., Duska, L.R., Crispens, M.A., Olawaiye, A.B., Winer, I.S., Barroilhet, L.M., Fu, S., McHale, M.T., Schilder, R.J., Farkkila, A., Curtis, J., Quinn, R., Whalen, C., Shapiro, G.I., Matulonis, U.A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Baseline platelet count and body weight as predictors of early dose modification in the quadra trial of niraparib monotherapy for the treatment of heavily pretreated (≥4th line), advanced, recurrent high-grade serous ovarian cancer
Matulonis, U.A., Monk, B.J., Secord, A.A., Geller, M.A., Miller, D.S., Cloven, N.G., Fleming, G.F., Hendrickson, A.E. Wahner, Azodi, M., DiSilvestro, P.A., Oza, A.M., Cristea, M., Berek, J.S., Chan, J.K., Li, Y., Luptakova, K., Hazard, S.J., Moore, K.N.
Published in Gynecologic oncology (01.06.2019)
Published in Gynecologic oncology (01.06.2019)
Get full text
Journal Article
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer
Konecny, G.E., Hendrickson, A.E. Wahner, Davidson, T.M., Winterhoff, B.J., Ma, S., Mahner, S., Sehouli, J., Fasching, P.A., Feisel-Schwickardi, G., Poelcher, M., Roman, L.D., Rody, A., Karlan, B.Y., Mullany, S.A., Chen, H., Ray-Coquard, I.L., Provencher, D.M., Yachnin, A., Cottu, P.H., Glaspy, J.A., Haluska, P., Slamon, D.J.
Published in Gynecologic oncology (01.12.2021)
Published in Gynecologic oncology (01.12.2021)
Get full text
Journal Article
A phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer
Wahner Hendrickson, A.E., Costello, B., Jewell, A., Kennedy, V., Fleming, G., Corr, B., Taylor, S.E., Lea, J., Reid, J., Swisher, E., Satele, D., Allred, J., Lensing, J., Ivy, S.P., Erlichman, C., Adjei, A.A., Kaufmann, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
QUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset
Moore, K.N., Secord, A.A., Geller, M., Miller, D.S., Cloven, N.G., Fleming, G.F., Wahner Hendrickson, A.E., Azodi, M., DiSilvestro, P., Oza, A., Cristea, M., Berek, J.S., Chan, J.K., Rimel, B.J., Li, Y., Luptakova, K., Clark, R., Matulonis, U.A., Monk, B.J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Insulin receptor isoform expression in ovarian cancer in African American women
Ali-Fehmi, R, Cote, M.L, Harrington, S.C, Block, M.S, Hartmann, L.C, Maurer, M.J, Kalli, K.R, Haluska, P
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article